Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rationale and targets for antifibrotic therapies.

Gastroenterologie clinique et biologique - 1 Jan 2000

Schuppan D, Popov Y

Abstract excerpt

We have made striking progress in our understanding of the biochemistry and cell biology that underlies liver fibrosis and cirrhosis, including the development of strategies and agents to prevent and reverse fibrosis and incipient cirrhosis. However, translation of this knowledge into clinical practice has been hampered by the limitation of many in vitro and in vivo models to confirm mechanisms and to test...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Angiotensin-Converting Enzyme Inhibitors
Share to Angiotensin II Type 1 Receptor Blockers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Peroxisome Proliferator-Activated Receptors

Share to Stem Cell Transplantation

Share to Transforming Growth Factor beta1

Source

Identifiers

PMID: 19726145
DOI: 10.1016/j.gcb.2009.07.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rationale and targets for antifibrotic therapies.PMID 19726145Read ↗

Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research AgendaSemantic proximity Read ↗

Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment conceptsSemantic proximity Read ↗

Models and Mechanisms of Fibrosis ResolutionSemantic proximity Read ↗

Fibrogenic cell reversion underlies fibrosis regression in liverSemantic proximity Read ↗

Molecular Mechanisms of Fibrosis in Cholestatic Liver Diseases and Regenerative Medicine-Based TherapiesSemantic proximity Read ↗

Mechanisms of hepatic fibrosis.Semantic proximity Read ↗

Mechanisms of liver fibrosisSemantic proximity Read ↗

Origin and Function of Myofibroblasts in the LiverSemantic proximity Read ↗

Liver fibrogenesis: un update on established and emerging basic conceptsSemantic proximity Read ↗

Liver fibrosis: cellular mechanisms of progression and resolutionSemantic proximity Read ↗

Multitranscriptome analyses reveal prioritized genes specifically associated with liver fibrosis progression independent of etiologySemantic proximity Read ↗

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.